| 10531 | Epo | erythropoietin | This gene encodes the glycoprotein hormone erythropoietin that regulates the production of red blood cells and biosynthesis of hemoglobin. The predominant expression of this gene shifts from the liver during fetal development to kidney in adults. A complete lack of the encoded protein causes embryon ic lethal anemia in mice. The conditional inactivation of this gene in adult mice results in a chronic, normocytic and normochromic anemia. Transgenic mice expressing the human ortholog of this gene exhibit polycythemia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015] | 5 | 137481282 | 137484078 | Mouse | 524 | symbol , PhenoGen | gene, protein-coding, REVIEWED [RefSeq] |
| 1323570 | Epx | eosinophil peroxidase | This gene encodes a member of the peroxidase superfamily of enzymes that is produced by eosinophils and plays a critical role in eliminating tissue-invasive parasites. The encoded preproprotein undergoes proteolytic processing to generate a heterodimeric enzyme that forms a predominant component of the intracellular granules of eosinophils. Mice lacking the encoded protein exhibit resistance to ulcerative colitis induced by dextran sulfate. [provided by RefSeq, Jul 2016] | 11 | 87754824 | 87766362 | Mouse | 93 | old_gene_symbol | gene, protein-coding, VALIDATED [RefSeq] |
| 10532 | Epor | erythropoietin receptor | Enables erythropoietin receptor activity. Involved in erythropoietin-mediated signaling pathway. Acts upstream of or within several processes, including brain development; decidualization; and heart development. Is active in plasma membrane. Is expressed in several structures, including egg cylinder ; embryo mesenchyme; genitourinary system; germ layer; and heart and pericardium. Used to study familial erythrocytosis 1. Human ortholog(s) of this gene implicated in anemia; familial erythrocytosis 1; high grade glioma; polycythemia; and systemic lupus erythematosus. Orthologous to human EPOR (erythropoietin receptor). [provided by Alliance of Genome Resources, Jul 2025] | 9 | 21870193 | 21874915 | Mouse | 346 | symbol , PhenoGen , description , old_gene_symbol | gene, protein-coding, VALIDATED [RefSeq] |
| 1322983 | Cnot9 | CCR4-NOT transcription complex, subunit 9 | Predicted to enable several functions, including epidermal growth factor receptor binding activity; protein homodimerization activity; and transcription coactivator activity. Acts upstream of or within cytokine-mediated signaling pathway. Located in P-body. Is expressed in several structures, includ ing alimentary system; brain; branchial arch; genitourinary system; and sensory organ. Orthologous to human CNOT9 (CCR4-NOT transcription complex subunit 9). [provided by Alliance of Genome Resources, Jul 2025] | 1 | 74545192 | 74570001 | Mouse | 113 | old_gene_name | gene, protein-coding, VALIDATED [RefSeq] |
| 1552553 | Zc3h15 | zinc finger CCCH-type containing 15 | Predicted to enable zinc ion binding activity. Acts upstream of or within cytokine-mediated signaling pathway. Predicted to be located in nucleus. Predicted to be active in cytosol. Is expressed in early conceptus; inner cell mass; and oocyte. Orthologous to human ZC3H15 (zinc finger CCCH-type conta ining 15). [provided by Alliance of Genome Resources, Apr 2025] | 2 | 83474922 | 83494961 | Mouse | 84 | old_gene_name , old_gene_symbol | gene, protein-coding, PROVISIONAL [RefSeq] |
| 1617432 | Epop | elongin BC and polycomb repressive complex 2 associated protein | Enables chromatin binding activity. Involved in regulation of transcription by RNA polymerase II; stem cell differentiation; and transcription elongation-coupled chromatin remodeling. Acts upstream of or within neuron fate commitment. Part of ESC/E(Z) complex and elongin complex. Is expressed in bra in. Orthologous to human EPOP (elongin BC and polycomb repressive complex 2 associated protein). [provided by Alliance of Genome Resources, Jul 2025] | 11 | 97518213 | 97520542 | Mouse | 85 | symbol , PhenoGen , description | gene, protein-coding, PROVISIONAL [RefSeq] |
| 1331943 | Pou2f3 | POU domain, class 2, transcription factor 3 | Enables identical protein binding activity and sequence-specific DNA binding activity. Involved in cell differentiation. Acts upstream of or within keratinocyte differentiation; positive regulation of transcription by RNA polymerase II; and wound healing. Located in nucleus. Part of transcription re gulator complex. Is expressed in several structures, including early conceptus; genitourinary system; gut; skin; and thymus. Orthologous to human POU2F3 (POU class 2 homeobox 3). [provided by Alliance of Genome Resources, Jul 2025] | 9 | 43035222 | 43117052 | Mouse | 120 | old_gene_symbol | gene, protein-coding, VALIDATED [RefSeq] |
| 731055 | Ephx2 | epoxide hydrolase 2, cytoplasmic | Enables epoxide hydrolase activity. Involved in several processes, including cholesterol homeostasis; epoxide metabolic process; and regulation of cholesterol metabolic process. Predicted to be located in cytosol. Predicted to be active in peroxisome. Is expressed in several structures, including eye; heart; integumental system; nervous system; and urinary system. Human ortholog(s) of this gene implicated in coronary artery disease; familial hypercholesterolemia; and hypertension. Orthologous to human EPHX2 (epoxide hydrolase 2). [provided by Alliance of Genome Resources, Jul 2025] | 14 | 66321821 | 66361971 | Mouse | 448 | old_gene_name , name , description | gene, protein-coding, VALIDATED [RefSeq] |
| 1316263 | Ephx3 | epoxide hydrolase 3 | Predicted to enable epoxide hydrolase activity. Predicted to be involved in epoxide metabolic process. Predicted to be located in membrane. Predicted to be active in intracellular membrane-bounded organelle. Orthologous to h uman EPHX3 (epoxide hydrolase 3). [provided by Alliance of Genome Resources, Apr 2025] | 17 | 32402742 | 32408444 | Mouse | 59 | name , description | gene, protein-coding, VALIDATED [RefSeq] |
| 1550275 | Cyp2c23 | cytochrome P450, family 2, subfamily c, polypeptide 23 | Predicted to enable arachidonate epoxygenase activity; heme binding activity; and oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen. Predicted to be involved in epoxygenase P450 pathway; icosanoid biosynthetic process; and xenobiotic metabolic process. Predicted to be located in endoplasmic reticulum membrane. Predicted to be active in cytoplasm and intracellular membrane-bounded organelle. Is expressed in metanephros; stomach; submandibular gland; and testis. Orthologous to human CYP2C23P (cytochrome P450 family 2 subfamily C member 23, pseudogene). [provided by Alliance of Genome Resources, Apr 2025] | 19 | 43993461 | 44017695 | Mouse | 93 | old_gene_name , description | gene, protein-coding, VALIDATED [RefSeq] |
| 1619904 | Cyp2c50 | cytochrome P450, family 2, subfamily c, polypeptide 50 | Enables arachidonate epoxygenase activity and linoleic acid epoxygenase activity. Acts upstream of or within arachidonate metabolic process and linoleic acid metabolic process. Predicted to be located in plasma membrane. Pre dicted to be active in cytoplasm and intracellular membrane-bounded organelle. Is expressed in alimentary system and liver. Human ortholog(s) of this gene implicated in several diseases, including Plasmodium falciparum malaria; carcinoma (multiple); end stage renal disease; glucose metabolism disease (multiple); and hypertension (multiple). Orthologous to several human genes including CYP2C18 (cytochrome P450 family 2 subfamily C member 18); CYP2C19 (cytochrome P450 family 2 subfamily C member 19); and CYP2C8 (cytochrome P450 family 2 subfamily C member 8). [provided by Alliance of Genome Resources, Apr 2025] | 19 | 40078123 | 40102399 | Mouse | 82 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 1614748 | Cyp2c54 | cytochrome P450, family 2, subfamily c, polypeptide 54 | Enables arachidonate epoxygenase activity and linoleic acid epoxygenase activity. Acts upstream of or within arachidonate metabolic process and linoleic acid metabolic process. Predicted to be located in endoplasmic reticulu m membrane. Predicted to be active in cytoplasm and intracellular membrane-bounded organelle. Human ortholog(s) of this gene implicated in end stage renal disease and renal hypertension. Orthologous to human CYP2C8 (cytochrome P450 family 2 subfamily C member 8). [provided by Alliance of Genome Resources, Apr 2025] | 19 | 40026383 | 40062289 | Mouse | 88 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 1322741 | Cyp2c55 | cytochrome P450, family 2, subfamily c, polypeptide 55 | Enables arachidonate epoxygenase activity and linoleic acid epoxygenase activity. Acts upstream of or within arachidonate metabolic process and linoleic acid metabolic process. Predicted to be located in plasma membrane. Pre dicted to be active in cytoplasm and intracellular membrane-bounded organelle. Orthologous to human CYP2C18 (cytochrome P450 family 2 subfamily C member 18). [provided by Alliance of Genome Resources, Apr 2025] | 19 | 38995384 | 39031134 | Mouse | 144 | description | gene, protein-coding, PROVISIONAL [RefSeq] |
| 10452 | Cyp2g1 | cytochrome P450, family 2, subfamily g, polypeptide 1 | Predicted to enable arachidonate epoxygenase activity; heme binding activity; and oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen. Predicted to be involved in epoxygenase P450 pathway and xenobiotic metabolic process. Predicted to be active in cytoplasm and intracellular membrane-bounded organelle. Is expressed in embryo; lung; and olfactory epithelium. Orthologous to human CYP2G1P (cytochrome P450 family 2 subfamily G member 1, pseudogene). [provided by Alliance of Genome Resources, Apr 2025] | 7 | 26508352 | 26520622 | Mouse | 69 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 1614004 | Cyp2t4 | cytochrome P450, family 2, subfamily t, polypeptide 4 | Predicted to enable arachidonate epoxygenase activity; heme binding activity; and oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen. Predicted to be involved in epoxygenase P450 pathway and xenobiotic metabolic process. Predicted to be active in cytoplasm and intracellular membrane-bounded organelle. Orthologous to human CYP2T1P (cytochrome P450 family 2 subfamily T member 1, pseudogene). [provided by Alliance of Genome Resources, Apr 2025] | 7 | 26853139 | 26857989 | Mouse | 24 | description | gene, protein-coding, PROVISIONAL [RefSeq] |
| 736676 | Sqle | squalene epoxidase | Predicted to enable FAD binding activity and squalene monooxygenase activity. Predicted to be involved in several processes, including lipid droplet formation; response to biphenyl; and sterol metabolic process. Predicted to be located in intracellular membrane-bounded organelle and membrane. Predic ted to be active in endoplasmic reticulum. Is expressed in several structures, including alimentary system; brain; genitourinary system; hemolymphoid system gland; and liver and biliary system. Orthologous to human SQLE (squalene epoxidase). [provided by Alliance of Genome Resources, Apr 2025] | 15 | 59186941 | 59203042 | Mouse | 426 | name , description | gene, protein-coding, PROVISIONAL [RefSeq] |
| 1617940 | Ephx4 | epoxide hydrolase 4 | Predicted to enable hydrolase activity. Predicted to be located in membrane. Orthologous to human EPHX4 (epoxide hydrolase 4). [provided by Alliance of Genome Resources, Jul 2025] | 5 | 107551379 | 107577901 | Mouse | 43 | old_gene_name , name , description | gene, protein-coding, VALIDATED [RefSeq] |
| 3795876 | AY358078 | cDNA sequence AY358078 | INTERACTS WITH epoxiconazole | 14 | 52037503 | 52063816 | Mouse | 4 | description | gene, protein-coding, PREDICTED [RefSeq] |
| 1618695 | Btg1b | BTG anti-proliferation factor 1B | INTERACTS WITH epoxiconazole | X | 37102050 | 37107727 | Mouse | 1 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 1617709 | Clec2j | C-type lectin domain family 2, member J | INTERACTS WITH epoxiconazole | 6 | 128631869 | 128633990 | Mouse | 1 | description | gene, pseudo, INFERRED [RefSeq] |
| 1619603 | Ear-ps8 | eosinophil-associated, ribonuclease A family, pseudogene 8 | INTERACTS WITH epoxiconazole | 14 | 44139137 | 44139603 | Mouse | 1 | description | gene, pseudo, INFERRED [RefSeq] |
| 1623834 | Gvin-ps6 | GTPase, very large interferon inducible, pseudogene 6 | INTERACTS WITH epoxiconazole | 7 | 106020757 | 106040280 | Mouse | 1 | description | gene, pseudo, VALIDATED [RefSeq] |
| 1614480 | Lipo5 | lipase, member O5 | INTERACTS WITH epoxiconazole | 19 | 33437523 | 33450581 | Mouse | 1 | description | gene, pseudo, INFERRED [RefSeq] |
| 1613757 | Potefam3d | POTE ankyrin domain family member 3D | INTERACTS WITH epoxiconazole | 8 | 69926245 | 69975576 | Mouse | 4 | description | gene, protein-coding, MODEL [RefSeq] |
| 1612563 | Rbm46os | RNA binding motif protein 46, opposite strand | INTERACTS WITH epoxiconazole | 3 | 82784012 | 82850945 | Mouse | 1 | description | gene, ncrna, VALIDATED [RefSeq] |
| 2294224 | Vmn1r100 | vomeronasal 1 receptor 100 | INTERACTS WITH epoxiconazole | 7 | 20151867 | 20152790 | Mouse | 1 | description | gene, protein-coding, PROVISIONAL [RefSeq] |
| 1618513 | Vmn1r155 | vomeronasal 1 receptor 155 | INTERACTS WITH epoxiconazole | 7 | 22357443 | 22358366 | Mouse | 3 | description | gene, protein-coding, PROVISIONAL [RefSeq] |
| 10529 | Ephx1 | epoxide hydrolase 1, microsomal | Enables oxysterol binding activity. Acts upstream of or within hydrocarbon catabolic process. Predicted to be located in intracellular membrane-bounded organelle and membrane. Is expressed in several structures, including brain ventricle and choroid plexus; exocrine system; integumental system; nerv ous system; and nose. Human ortholog(s) of this gene implicated in several diseases, including Leber hereditary optic neuropathy; anemia (multiple); hematologic cancer (multiple); respiratory system disease (multiple); and toxic encephalopathy. Orthologous to human EPHX1 (epoxide hydrolase 1). [provided by Alliance of Genome Resources, Apr 2025] | 1 | 180817121 | 180845134 | Mouse | 657 | old_gene_name , name , description | gene, protein-coding, VALIDATED [RefSeq] |
| 1617470 | Csmd2os | CUB and Sushi multiple domains 2, opposite strand | INTERACTS WITH epoxiconazole; genistein | | | | Mouse | 2 | description | gene, ncrna |
| 1611033 | Grin1os | glutamate receptor, ionotropic, NMDA1 (zeta 1), opposite strand | INTERACTS WITH epoxiconazole; triptonide | 2 | 25181270 | 25188672 | Mouse | 5 | description | gene, ncrna, VALIDATED [RefSeq] |
| 2308132 | Tdpoz7 | Td and POZ domain containing 7 | INTERACTS WITH epoxiconazole; triptonide | 3 | 93978929 | 93979951 | Mouse | 2 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 1613764 | Rpl31-ps12 | ribosomal protein L31, pseudogene 1 2 | INTERACTS WITH bisphenol A; epoxiconazole | 16 | 16637577 | 16638060 | Mouse | 2 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 10043399 | Phxr2 | per-hexamer repeat gene 2 | INTERACTS WITH epoxiconazole; methotrexate | | | | Mouse | 5 | description | gene, ncrna |
| 1332416 | Vkorc1 | vitamin K epoxide reductase complex, subunit 1 | Vitamin K is essential for blood clotting but must be enzymatically activated. This enzymatically activated form of vitamin K is a reduced form required for the carboxylation of glutamic acid residues in some blood-clotting proteins. The product of this gene encodes the enzyme that is responsible fo r reducing vitamin K 2,3-epoxide to the enzymatically activated form. Fatal bleeding can be caused by vitamin K deficiency and by the vitamin K antagonist warfarin, and it is the product of this gene that is sensitive to warfarin. In humans, mutations in this gene can be associated with deficiencies in vitamin-K-dependent clotting factors and, in humans and rats, with warfarin resistance. [provided by RefSeq, Jul 2008] | 7 | 127492235 | 127494833 | Mouse | 272 | old_gene_name , name , description | gene, protein-coding, REVIEWED [RefSeq] |
| 1622828 | Speer4e1 | spermatogenesis associated glutamate (E)-rich protein 4E1 | INTERACTS WITH atrazine; chlorpyrifos; epoxiconazole | 5 | 14983645 | 14988489 | Mouse | 7 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 1551455 | Vkorc1l1 | vitamin K epoxide reductase complex, subunit 1-like 1 | Enables vitamin-K-epoxide reductase (warfarin-sensitive) activity. Involved in vitamin K metabolic process. Is active in endoplasmic reticulum membrane. Is expressed in liver. Orthologous to human VKORC1L1 (vitamin K epoxide reductase complex subunit 1 like 1). [provided by Alliance of Genome Resources, Jul 2025] | 5 | 129970950 | 130015533 | Mouse | 151 | old_gene_name , name , description | gene, protein-coding, VALIDATED [RefSeq] |
| 1617099 | Potefam2 | POTE ankyrin domain family member 2 | INTERACTS WITH atrazine; bis(2-ethylhexyl) phthalate; epoxiconazole | 7 | 62396565 | 62473491 | Mouse | 4 | description | gene, protein-coding, MODEL [RefSeq] |
| 1615812 | Spaca7b | sperm acrosome associated 7B | FOUND IN acrosomal vesicle (inferred); INTERACTS WITH epoxiconazole | 8 | 11705478 | 11728749 | Mouse | 5 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 1616421 | Zfp781b | zinc finger protein 781B | INTERACTS WITH 1,2-dichloroethane; dibutyl phthalate; epoxiconazole | 10 | 81737512 | 81766655 | Mouse | 8 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 1623562 | Gvin3 | GTPase, very large interferon inducible, family member 3 | INTERACTS WITH 17beta-estradiol; 4,4'-sulfonyldiphenol; epoxiconazole | 7 | 106194756 | 106243853 | Mouse | 4 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 1620803 | Ms4a20 | membrane-spanning 4-domains, subfamily A, member 20 | INTERACTS WITH Butylbenzyl phthalate; epoxiconazole; titanium dioxide | 19 | 11074178 | 11108253 | Mouse | 5 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 1620957 | Scgb2b17 | secretoglobin, family 2B, member 17 | FOUND IN extracellular space (inferred); INTERACTS WITH epoxiconazole | 7 | 32754007 | 32755977 | Mouse | 5 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 2302502 | Scgb1b17 | secretoglobin, family 1B, member 17 | FOUND IN extracellular region (inferred); INTERACTS WITH epoxiconazole | 7 | 32762890 | 32764071 | Mouse | 4 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 2307939 | Btbd35f13 | BTB domain containing 35, family member 13 | INVOLVED IN germ cell development (inferred); INTERACTS WITH epoxiconazole | X | 33094603 | 33096545 | Mouse | 4 | description | gene, protein-coding, INFERRED [RefSeq] |
| 7180323 | Btbd35f22 | BTB domain containing 35, family member 22 | INVOLVED IN germ cell development (inferred); INTERACTS WITH epoxiconazole | X | 31608508 | 31610318 | Mouse | 2 | description | gene, protein-coding, MODEL [RefSeq] |
| 1312428 | Mospd4 | motile sperm domain containing 4 | INTERACTS WITH 1,2-dimethylhydrazine; 4,4'-sulfonyldiphenol; epoxiconazole | 18 | 46598001 | 46598883 | Mouse | 5 | description | gene, pseudo, VALIDATED [RefSeq] |
| 1320308 | Potefam1 | POTE ankyrin domain family member 1 | INTERACTS WITH epoxiconazole; beauvericin (ortholog); bisphenol A (ortholog) | 2 | 110880755 | 111059948 | Mouse | 10 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 1623318 | Cyp2j5 | cytochrome P450, family 2, subfamily j, polypeptide 5 | Predicted to enable heme binding activity; isomerase activity; and monooxygenase activity. Acts upstream of or within angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure; positive regulation of estrogen secretion; and renal tubular secretion. Predicted to be located in endoplasmic reticulum membrane. Predicted to be active in cytoplasm and intracellular membrane-bounded organelle. Is expressed in liver and metanephros. Human ortholog(s) of this gene implicated in hypertension; myocardial infarction; pulmonary hypertension; renal fibrosis; and renal hypertension. Orthologous to human CYP2J2 (cytochrome P450 family 2 subfamily J member 2). [provided by Alliance of Genome Resources, Apr 2025] | 4 | 96517010 | 96552391 | Mouse | 88 | old_gene_name | gene, protein-coding, VALIDATED [RefSeq] |
| 1550170 | Cyp2j6 | cytochrome P450, family 2, subfamily j, polypeptide 6 | Enables arachidonate epoxygenase activity. Predicted to be involved in several processes, including negative regulation of peroxisome proliferator activated receptor signaling pathway; regulation of biosynthetic process; and unsaturated fatty acid metabolic proc ess. Located in endoplasmic reticulum. Is expressed in several structures, including alimentary system; integumental system; metanephros; nervous system; and sensory organ. Human ortholog(s) of this gene implicated in hypertension; myocardial infarction; pulmonary hypertension; renal fibrosis; and renal hypertension. Orthologous to human CYP2J2 (cytochrome P450 family 2 subfamily J member 2). [provided by Alliance of Genome Resources, Apr 2025] | 4 | 96404375 | 96449835 | Mouse | 69 | old_gene_name , description | gene, protein-coding, VALIDATED [RefSeq] |
| 1619566 | Taf7l2 | Taf7l2 | INTERACTS WITH all-trans-retinoic acid; epoxiconazole; mono(2-ethylhexyl) phthalate | 10 | 115947569 | 115949822 | Mouse | 5 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 1615011 | Cyp4f41-ps | cytochrome P450, family 4, subfamily f, polypeptide 41 pseudogene | INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 4,4'-sulfonyldiphenol; epoxiconazole | 17 | 33169935 | 33184690 | Mouse | 4 | description | gene, pseudo, VALIDATED [RefSeq] |
| 733768 | Lss | lanosterol synthase | This gene encodes an enzyme that catalyzes the conversion of (S)-2,3 oxidosqualene to lanosterol. The encoded protein is a member of the terpene cyclase/mutase family and catalyzes the first step in the biosynthesis of cholesterol, steroid hormones, and vitamin D. [provided by RefSeq, Feb 2015] | 10 | 76367303 | 76392973 | Mouse | 401 | old_gene_name | gene, protein-coding, REVIEWED [RefSeq] |
| 1623474 | Nlrp1c-ps | NLR family, pyrin domain containing 1C, pseudogene | INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; epoxiconazole; mono(2-ethylhexyl) phthalate | 11 | 71133256 | 71176058 | Mouse | 3 | description | gene, pseudo, VALIDATED [RefSeq] |
| 733162 | Ebp | EBP cholestenol delta-isomerase | This gene encodes a transmembrane protein that localizes to the endoplasmic reticulum. This protein catalyses the conversion of delta8 to delta7 sterols, an important step in sterol biosynthesis. Mutations in this gene are responsible for the mouse tattered mutant phenotype. Tattered males are embry onic lethal, while heterozygous females have developmental defects. Deficiency of the related gene in human causes X-linked dominant chondrodysplasia punctata. [provided by RefSeq, May 2015] | X | 8051568 | 8059751 | Mouse | 277 | old_gene_name | gene, protein-coding, REVIEWED [RefSeq] |
| 731756 | Dhcr7 | 7-dehydrocholesterol reductase | Enables 7-dehydrocholesterol reductase activity. Acts upstream of or within several processes, including blood vessel development; lung epithelial cell differentiation; and sterol biosynthetic process. Predicted to be located in endoplasmic reticulum and nuclear outer membrane. Predicted to be activ e in endoplasmic reticulum membrane. Is expressed in adrenal gland; genitourinary system; and neural retina. Used to study Smith-Lemli-Opitz syndrome. Human ortholog(s) of this gene implicated in Behcet's disease and Smith-Lemli-Opitz syndrome. Orthologous to human DHCR7 (7-dehydrocholesterol reductase). [provided by Alliance of Genome Resources, Jul 2025] | 7 | 143376827 | 143402147 | Mouse | 457 | old_gene_name | gene, protein-coding, VALIDATED [RefSeq] |
| 1613745 | Aadacl2fm3 | AADACL2 family member 3 | ENCODES a protein that exhibits carboxylic ester hydrolase activity (inferred); catalytic activity (inferred); hydrolase activity (inferred); FOUND IN membrane (inferred); INTERACTS WITH epoxiconazole; 1-naphthyl isothiocyanate (ortholog); 4,4'-diaminodiphenylme thane (ortholog) | 3 | 59768472 | 59784734 | Mouse | 11 | description | gene, protein-coding, PREDICTED [RefSeq] |
| 732684 | Akr7a5 | aldo-keto reductase family 7, member A5 | Predicted to enable aldose reductase (NADPH) activity; identical protein binding activity; and phenanthrene-9,10-epoxide hydrolase activity. Predicted to be involved in lipid metabolic process. Located in mitochondrion. Is expressed in cerebral cortex ventricula r layer. Orthologous to several human genes including AKR7A2 (aldo-keto reductase family 7 member A2). [provided by Alliance of Genome Resources, Apr 2025] | 4 | 139038005 | 139046097 | Mouse | 229 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 1315060 | Ccdc202 | coiled-coil domain containing 202 | INTERACTS WITH epoxiconazole; 2,3,7,8-tetrachlorodibenzodioxine (ortholog); 3-isobutyl-1-methyl-7H-xanthine (ortholog) | 14 | 96114791 | 96120216 | Mouse | 23 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 1332108 | Cyp2a12 | cytochrome P450, family 2, subfamily a, polypeptide 12 | Predicted to enable heme binding activity and monooxygenase activity. Predicted to be involved in coumarin metabolic process; epoxygenase P450 pathway; and xenobiotic metabolic process. Predicted to be located in endoplasmic reticulum membrane. Predicted to be a ctive in cytoplasm and intracellular membrane-bounded organelle. Is expressed in liver. Orthologous to human CYP2A13 (cytochrome P450 family 2 subfamily A member 13); CYP2A6 (cytochrome P450 family 2 subfamily A member 6); and CYP2A7 (cytochrome P450 family 2 subfamily A member 7). [provided by Alliance of Genome Resources, Apr 2025] | 7 | 26728515 | 26736243 | Mouse | 62 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 1621331 | Cyp2a22 | cytochrome P450, family 2, subfamily a, polypeptide 22 | Predicted to enable heme binding activity and monooxygenase activity. Predicted to be involved in coumarin metabolic process; epoxygenase P450 pathway; and xenobiotic metabolic process. Predicted to be active in cytoplasm and intracellular membrane-bounded organ elle. Orthologous to human CYP2A13 (cytochrome P450 family 2 subfamily A member 13); CYP2A6 (cytochrome P450 family 2 subfamily A member 6); and CYP2A7 (cytochrome P450 family 2 subfamily A member 7). [provided by Alliance of Genome Resources, Apr 2025] | 7 | 26631564 | 26638838 | Mouse | 146 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 1624099 | Cyp2b13 | cytochrome P450, family 2, subfamily b, polypeptide 13 | Predicted to enable heme binding activity and monooxygenase activity. Predicted to be involved in several processes, including epoxygenase P450 pathway; steroid metabolic process; and xenobiotic catabolic process. Predicted to be active in cytoplasm and intracel lular membrane-bounded organelle. Is expressed in liver. Human ortholog(s) of this gene implicated in several diseases, including acute myeloid leukemia; drug dependence (multiple); human immunodeficiency virus infectious disease; neonatal abstinence syndrome; and nicotine dependence. Orthologous to human CYP2B6 (cytochrome P450 family 2 subfamily B member 6). [provided by Alliance of Genome Resources, Apr 2025] | 7 | 25760813 | 25795622 | Mouse | 308 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 736410 | Cyp2b19 | cytochrome P450, family 2, subfamily b, polypeptide 19 | Predicted to enable heme binding activity and monooxygenase activity. Predicted to be involved in several processes, including epoxygenase P450 pathway; steroid metabolic process; and xenobiotic catabolic process. Predicted to be located in endoplasmic reticulum membrane. Predicted to be active in cytoplasm and intracellular membrane-bounded organelle. Is expressed in several structures, including alimentary system; nervous system; respiratory system; sensory organ; and skin. Human ortholog(s) of this gene implicated in several diseases, including acute myeloid leukemia; drug dependence (multiple); human immunodeficiency virus infectious disease; neonatal abstinence syndrome; and nicotine dependence. Orthologous to human CYP2B6 (cytochrome P450 family 2 subfamily B member 6). [provided by Alliance of Genome Resources, Apr 2025] | 7 | 26456567 | 26472055 | Mouse | 45 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 1618108 | Cyp2b23 | cytochrome P450, family 2, subfamily b, polypeptide 23 | Predicted to enable heme binding activity and monooxygenase activity. Predicted to be involved in several processes, including epoxygenase P450 pathway; steroid metabolic process; and xenobiotic catabolic process. Predicted to be active in cytoplasm and intracel lular membrane-bounded organelle. Human ortholog(s) of this gene implicated in several diseases, including acute myeloid leukemia; drug dependence (multiple); human immunodeficiency virus infectious disease; neonatal abstinence syndrome; and nicotine dependence. Orthologous to human CYP2B6 (cytochrome P450 family 2 subfamily B member 6). [provided by Alliance of Genome Resources, Apr 2025] | 7 | 26364652 | 26389788 | Mouse | 39 | description | gene, protein-coding, PROVISIONAL [RefSeq] |
| 734157 | Cyp2c29 | cytochrome P450, family 2, subfamily c, polypeptide 29 | Enables arachidonate 14,15-epoxygenase activity. Involved in arachidonate metabolic process. Predicted to be located in plasma membrane. Predicted to be active in cytoplasm and intracellular membrane-bounded organelle. Is expressed in several structures, includi ng genitourinary system; liver; lung; nervous system; and spleen. Human ortholog(s) of this gene implicated in several diseases, including Plasmodium falciparum malaria; carcinoma (multiple); eosinophilic esophagitis; glucose metabolism disease (multiple); and heroin dependence. Orthologous to human CYP2C18 (cytochrome P450 family 2 subfamily C member 18); CYP2C19 (cytochrome P450 family 2 subfamily C member 19); and CYP2C9 (cytochrome P450 family 2 subfamily C member 9). [provided by Alliance of Genome Resources, Apr 2025] | 19 | 39275541 | 39319157 | Mouse | 632 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 1624096 | Cyp2c38 | cytochrome P450, family 2, subfamily c, polypeptide 38 | Enables arachidonate 11,12-epoxygenase activity and arachidonate 14,15-epoxygenase activity. Involved in arachidonate metabolic process. Predicted to be located in plasma membrane. Predicted to be active in cytoplasm and int racellular membrane-bounded organelle. Is expressed in liver. Human ortholog(s) of this gene implicated in several diseases, including Plasmodium falciparum malaria; carcinoma (multiple); eosinophilic esophagitis; glucose metabolism disease (multiple); and heroin dependence. Orthologous to human CYP2C18 (cytochrome P450 family 2 subfamily C member 18); CYP2C19 (cytochrome P450 family 2 subfamily C member 19); and CYP2C9 (cytochrome P450 family 2 subfamily C member 9). [provided by Alliance of Genome Resources, Apr 2025] | 19 | 39379109 | 39451519 | Mouse | 652 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 1624095 | Cyp2c39 | cytochrome P450, family 2, subfamily c, polypeptide 39 | Enables arachidonate 11,12-epoxygenase activity. Involved in arachidonate metabolic process. Predicted to be located in plasma membrane. Predicted to be active in cytoplasm and intracellular membrane-bounded organelle. Is expressed in liver. Human ortholog(s) of this gene implicated in several diseases, including Plasmodium falciparum malaria; carcinoma (multiple); eosinophilic esophagitis; glucose metabolism disease (multiple); and heroin dependence. Orthologous to human CYP2C18 (cytochrome P450 family 2 subfamily C member 18); CYP2C19 (cytochrome P450 family 2 subfamily C member 19); and CYP2C9 (cytochrome P450 family 2 subfamily C member 9). [provided by Alliance of Genome Resources, Apr 2025] | 19 | 39335790 | 39558012 | Mouse | 91 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 1558409 | Cyp2c40 | cytochrome P450, family 2, subfamily c, polypeptide 40 | Enables arachidonate 14,15-epoxygenase activity. Predicted to be involved in organic acid metabolic process and xenobiotic metabolic process. Predicted to be located in endoplasmic reticulum membrane. Predicted to be active in cytoplasm and intracellular membran e-bounded organelle. Is expressed in embryo; liver; and metanephros. Human ortholog(s) of this gene implicated in end stage renal disease and renal hypertension. Orthologous to human CYP2C8 (cytochrome P450 family 2 subfamily C member 8). [provided by Alliance of Genome Resources, Apr 2025] | 19 | 39755517 | 39801258 | Mouse | 81 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 2295251 | Cyp2c52-ps | cytochrome P450, family 2, subfamily c, polypeptide 52, pseudogene | ENCODES a pseudogene that exhibits arachidonate 11,12-epoxygenase activity (ortholog); arachidonate 14,15-epoxygenase activity (ortholog); monooxygenase activity (ortholog); INVOLVED IN epo an>xygenase P450 pathway (ortholog); icosanoid biosynthetic process (ortholog); retinoic acid metabolic process (ortholog); PARTICIPATES IN forkhead class A signaling pathway; warfarin pharmacokinetics pathway; ASSOCIATED WITH Cardiomegaly (ortholog); Chemical and Drug Induced Liver Injury (ortholog); depressive disorder (ortholog); FOUND IN endoplasmic reticulum membrane (ortholog); INTERACTS WITH (1->4)-beta-D-glucan; 2,3,7,8-tetrachlorodibenzodioxine; 5-aza-2'-deoxycytidine | 19 | 38965106 | 38992071 | Mouse | 318 | description | gene, pseudo, INFERRED [RefSeq] |
| 1623319 | Cyp2d10 | cytochrome P450, family 2, subfamily d, polypeptide 10 | Predicted to enable anandamide epoxidase activity; aromatase activity; and heme binding activity. Predicted to be involved in arachidonate metabolic process and xenobiotic metabolic process. Predicted to be located in mitochondrion. Predicted to be active in cyt oplasm and intracellular membrane-bounded organelle. Is expressed in alimentary system; liver; and urinary system. Human ortholog(s) of this gene implicated in several diseases, including autoimmune hepatitis; extrapyramidal and movement disease; head and neck squamous cell carcinoma; leukemia (multiple); and major depressive disorder. Orthologous to human CYP2D6 (cytochrome P450 family 2 subfamily D member 6 (gene/pseudogene)) and CYP2D7 (cytochrome P450 family 2 subfamily D member 7 (gene/pseudogene)). [provided by Alliance of Genome Resources, Apr 2025] | 15 | 82287046 | 82291449 | Mouse | 67 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 1613206 | Cyp2d11 | cytochrome P450, family 2, subfamily d, polypeptide 11 | Predicted to enable anandamide epoxidase activity; aromatase activity; and heme binding activity. Predicted to be involved in arachidonate metabolic process and xenobiotic metabolic process. Predicted to be located in mitochondrion. Predicted to be active in cyt oplasm and intracellular membrane-bounded organelle. Human ortholog(s) of this gene implicated in several diseases, including autoimmune hepatitis; extrapyramidal and movement disease; head and neck squamous cell carcinoma; leukemia (multiple); and major depressive disorder. Orthologous to human CYP2D6 (cytochrome P450 family 2 subfamily D member 6 (gene/pseudogene)) and CYP2D7 (cytochrome P450 family 2 subfamily D member 7 (gene/pseudogene)). [provided by Alliance of Genome Resources, Apr 2025] | 15 | 82273355 | 82278223 | Mouse | 41 | description | gene, protein-coding, PROVISIONAL [RefSeq] |
| 1623678 | Cyp2d12 | cytochrome P450, family 2, subfamily d, polypeptide 12 | Predicted to enable anandamide epoxidase activity; aromatase activity; and heme binding activity. Predicted to be involved in arachidonate metabolic process and xenobiotic metabolic process. Predicted to be located in mitochondrion. Predicted to be active in cyt oplasm and intracellular membrane-bounded organelle. Human ortholog(s) of this gene implicated in several diseases, including autoimmune hepatitis; extrapyramidal and movement disease; head and neck squamous cell carcinoma; leukemia (multiple); and major depressive disorder. Orthologous to human CYP2D6 (cytochrome P450 family 2 subfamily D member 6 (gene/pseudogene)) and CYP2D7 (cytochrome P450 family 2 subfamily D member 7 (gene/pseudogene)). [provided by Alliance of Genome Resources, Apr 2025] | 15 | 82439244 | 82443614 | Mouse | 53 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 1550436 | Cyp2d26 | cytochrome P450, family 2, subfamily d, polypeptide 26 | Predicted to enable anandamide epoxidase activity; aromatase activity; and heme binding activity. Predicted to be involved in arachidonate metabolic process and xenobiotic metabolic process. Predicted to be located in mitochondrion. Predicted to be active in cyt oplasm and intracellular membrane-bounded organelle. Is expressed in several structures, including genitourinary system; liver; lung; and skeletal muscle. Human ortholog(s) of this gene implicated in several diseases, including autoimmune hepatitis; extrapyramidal and movement disease; head and neck squamous cell carcinoma; leukemia (multiple); and major depressive disorder. Orthologous to human CYP2D6 (cytochrome P450 family 2 subfamily D member 6 (gene/pseudogene)) and CYP2D7 (cytochrome P450 family 2 subfamily D member 7 (gene/pseudogene)). [provided by Alliance of Genome Resources, Apr 2025] | 15 | 82674308 | 82678653 | Mouse | 63 | description | gene, protein-coding, PROVISIONAL [RefSeq] |
| 1622988 | Cyp2d34 | cytochrome P450, family 2, subfamily d, polypeptide 34 | Predicted to enable anandamide epoxidase activity; aromatase activity; and heme binding activity. Predicted to be involved in arachidonate metabolic process and xenobiotic metabolic process. Predicted to be located in mitochondrion. Predicted to be active in cyt oplasm and intracellular membrane-bounded organelle. Human ortholog(s) of this gene implicated in several diseases, including autoimmune hepatitis; extrapyramidal and movement disease; head and neck squamous cell carcinoma; leukemia (multiple); and major depressive disorder. Orthologous to human CYP2D6 (cytochrome P450 family 2 subfamily D member 6 (gene/pseudogene)) and CYP2D7 (cytochrome P450 family 2 subfamily D member 7 (gene/pseudogene)). [provided by Alliance of Genome Resources, Apr 2025] | 15 | 82500164 | 82505157 | Mouse | 51 | description | gene, protein-coding, PROVISIONAL [RefSeq] |
| 1622276 | Cyp2d40 | cytochrome P450, family 2, subfamily d, polypeptide 40 | Predicted to enable anandamide epoxidase activity; aromatase activity; and heme binding activity. Predicted to be located in mitochondrion. Human ortholog(s) of this gene implicated in several diseases, including autoimmune hepatitis; extrapyramidal and movement disease; head and neck squamous cell carcinoma; leukemia (multiple); and major depressive disorder. Orthologous to human CYP2D6 (cytochrome P450 family 2 subfamily D member 6 (gene/pseudogene)) and CYP2D7 (cytochrome P450 family 2 subfamily D member 7 (gene/pseudogene)). [provided by Alliance of Genome Resources, Jul 2025] | 15 | 82644034 | 82648323 | Mouse | 38 | description | gene, protein-coding, PROVISIONAL [RefSeq] |
| 734451 | Cyp2d9 | cytochrome P450, family 2, subfamily d, polypeptide 9 | Predicted to enable anandamide epoxidase activity; aromatase activity; and heme binding activity. Predicted to be involved in arachidonate metabolic process and xenobiotic metabolic process. Predicted to be located in mitochondrion. Predicted to be active in cyt oplasm and intracellular membrane-bounded organelle. Is expressed in alimentary system; liver; and urinary system. Human ortholog(s) of this gene implicated in several diseases, including autoimmune hepatitis; extrapyramidal and movement disease; head and neck squamous cell carcinoma; leukemia (multiple); and major depressive disorder. Orthologous to human CYP2D6 (cytochrome P450 family 2 subfamily D member 6 (gene/pseudogene)) and CYP2D7 (cytochrome P450 family 2 subfamily D member 7 (gene/pseudogene)). [provided by Alliance of Genome Resources, Apr 2025] | 15 | 82336578 | 82341028 | Mouse | 85 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 733763 | Cyp2f2 | cytochrome P450, family 2, subfamily f, polypeptide 2 | Predicted to enable arachidonate epoxygenase activity; heme binding activity; and oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen. Acts upstream of or within naphthalene catabolic process and response to toxic substance. Predicted to be located in endoplasmic reticulum membrane. Predicted to be active in cytoplasm and intracellular membrane-bounded organelle. Is expressed in several structures, including alimentary system; nose; pharyngo-tympanic tube; respiratory system; and sublingual gland primordium. Orthologous to several human genes including CYP2F1 (cytochrome P450 family 2 subfamily F member 1). [provided by Alliance of Genome Resources, Apr 2025] | 7 | 26819380 | 26833085 | Mouse | 212 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 1614241 | Cyp2j11 | cytochrome P450, family 2, subfamily j, polypeptide 11 | Predicted to enable heme binding activity; isomerase activity; and monooxygenase activity. Predicted to be involved in epoxygenase P450 pathway; linoleic acid metabolic process; and xenobiotic metabolic process. Predicted to be active in cytoplasm and intracellu lar membrane-bounded organelle. Human ortholog(s) of this gene implicated in hypertension; myocardial infarction; pulmonary hypertension; renal fibrosis; and renal hypertension. Orthologous to human CYP2J2 (cytochrome P450 family 2 subfamily J member 2). [provided by Alliance of Genome Resources, Apr 2025] | 4 | 96182745 | 96236930 | Mouse | 34 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 1626606 | Cyp2j12 | cytochrome P450, family 2, subfamily j, polypeptide 12 | Predicted to enable heme binding activity; isomerase activity; and monooxygenase activity. Predicted to be involved in epoxygenase P450 pathway; linoleic acid metabolic process; and xenobiotic metabolic process. Predicted to be active in cytoplasm and intracellu lar membrane-bounded organelle. Human ortholog(s) of this gene implicated in hypertension; myocardial infarction; pulmonary hypertension; renal fibrosis; and renal hypertension. Orthologous to human CYP2J2 (cytochrome P450 family 2 subfamily J member 2). [provided by Alliance of Genome Resources, Apr 2025] | 4 | 95987553 | 96029389 | Mouse | 24 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 1621333 | Cyp2j13 | cytochrome P450, family 2, subfamily j, polypeptide 13 | Predicted to enable heme binding activity; isomerase activity; and monooxygenase activity. Predicted to be involved in epoxygenase P450 pathway; linoleic acid metabolic process; and xenobiotic metabolic process. Predicted to be active in cytoplasm and intracellu lar membrane-bounded organelle. Human ortholog(s) of this gene implicated in hypertension; myocardial infarction; pulmonary hypertension; renal fibrosis; and renal hypertension. Orthologous to human CYP2J2 (cytochrome P450 family 2 subfamily J member 2). [provided by Alliance of Genome Resources, Apr 2025] | 4 | 95930897 | 95965803 | Mouse | 49 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 1607118 | Cyp2j7 | cytochrome P450, family 2, subfamily j, polypeptide 7 | Predicted to enable heme binding activity; isomerase activity; and monooxygenase activity. Predicted to be involved in epoxygenase P450 pathway; linoleic acid metabolic process; and xenobiotic metabolic process. Predicted to be active in cytoplasm and intracellu lar membrane-bounded organelle. Human ortholog(s) of this gene implicated in hypertension; myocardial infarction; pulmonary hypertension; renal fibrosis; and renal hypertension. Orthologous to human CYP2J2 (cytochrome P450 family 2 subfamily J member 2). [provided by Alliance of Genome Resources, Apr 2025] | 4 | 96082684 | 96124896 | Mouse | 26 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 1607117 | Cyp2j8 | cytochrome P450, family 2, subfamily j, polypeptide 8 | Predicted to enable heme binding activity; isomerase activity; and monooxygenase activity. Predicted to be involved in epoxygenase P450 pathway; linoleic acid metabolic process; and xenobiotic metabolic process. Predicted to be active in cytoplasm and intracellu lar membrane-bounded organelle. Human ortholog(s) of this gene implicated in hypertension; myocardial infarction; pulmonary hypertension; renal fibrosis; and renal hypertension. Orthologous to human CYP2J2 (cytochrome P450 family 2 subfamily J member 2). [provided by Alliance of Genome Resources, Apr 2025] | 4 | 96332187 | 96395634 | Mouse | 31 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 1550962 | Cyp2j9 | cytochrome P450, family 2, subfamily j, polypeptide 9 | Predicted to enable heme binding activity; isomerase activity; and monooxygenase activity. Predicted to be involved in epoxygenase P450 pathway; linoleic acid metabolic process; and xenobiotic metabolic process. Located in endoplasmic reticulum. Is expressed in alimentary system; ductus arteriosus; nervous system; and sensory organ. Human ortholog(s) of this gene implicated in hypertension; myocardial infarction; pulmonary hypertension; renal fibrosis; and renal hypertension. Orthologous to human CYP2J2 (cytochrome P450 family 2 subfamily J member 2). [provided by Alliance of Genome Resources, Jul 2025] | 4 | 96456661 | 96480748 | Mouse | 287 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 731279 | Cyp4x1 | cytochrome P450, family 4, subfamily x, polypeptide 1 | Predicted to enable anandamide 14,15 epoxidase activity. Predicted to be involved in lipid metabolic process. Predicted to be located in endoplasmic reticulum membrane. Is expressed in several structures, including genitourinary system; heart; nervous system; an d neural retina. Orthologous to human CYP4X1 (cytochrome P450 family 4 subfamily X member 1). [provided by Alliance of Genome Resources, Apr 2025] | 4 | 114963518 | 114991276 | Mouse | 85 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 2307513 | Scgb2b11 | secretoglobin, family 2B, member 11 | FOUND IN extracellular region (inferred); extracellular space (inferred); INTERACTS WITH epoxiconazole | 7 | 31908598 | 31910567 | Mouse | 6 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 2313707 | Snora78 | small nucleolar RNA, H/ACA box 7 | INVOLVED IN RNA processing (inferred); FOUND IN nucleolus (inferred); INTERACTS WITH benzo[a]pyrene diol epoxide I (ortholog); sodium arsenite (ortholog) | 17 | 24938650 | 24938806 | Mouse | 7 | description | gene, snorna, VALIDATED [RefSeq] |
| 1618704 | Vmn1r113 | vomeronasal 1 receptor 113 | ENCODES a protein that exhibits G protein-coupled receptor activity (inferred); pheromone receptor activity (inferred); INVOLVED IN G protein-coupled receptor signaling pathway (inferred); response to pheromone (inferred); sensory perception of chemical stimulus (inferred); FOUND IN membrane (inferr ed); plasma membrane (inferred); INTERACTS WITH epoxiconazole | 7 | 20521210 | 20522133 | Mouse | 15 | description | gene, protein-coding, PROVISIONAL [RefSeq] |
| 1620979 | Vmn1r116 | vomeronasal 1 receptor 116 | ENCODES a protein that exhibits G protein-coupled receptor activity (inferred); pheromone receptor activity (inferred); INVOLVED IN G protein-coupled receptor signaling pathway (inferred); response to pheromone (inferred); sensory perception of chemical stimulus (inferred); FOUND IN membrane (inferr ed); plasma membrane (inferred); INTERACTS WITH epoxiconazole | 7 | 20606181 | 20607104 | Mouse | 15 | description | gene, protein-coding, PROVISIONAL [RefSeq] |
| 1614755 | Vmn1r123 | vomeronasal 1 receptor 123 | ENCODES a protein that exhibits G protein-coupled receptor activity (inferred); pheromone receptor activity (inferred); INVOLVED IN G protein-coupled receptor signaling pathway (inferred); response to pheromone (inferred); sensory perception of chemical stimulus (inferred); FOUND IN membrane (inferr ed); plasma membrane (inferred); INTERACTS WITH epoxiconazole | 7 | 20896110 | 20897033 | Mouse | 15 | description | gene, protein-coding, PROVISIONAL [RefSeq] |
| 1619348 | Vmn1r143 | vomeronasal 1 receptor 143 | ENCODES a protein that exhibits G protein-coupled receptor activity (inferred); pheromone receptor activity (inferred); INVOLVED IN G protein-coupled receptor signaling pathway (inferred); response to pheromone (inferred); sensory perception of chemical stimulus (inferred); FOUND IN membrane (inferr ed); plasma membrane (inferred); INTERACTS WITH epoxiconazole | 7 | 21888802 | 21889725 | Mouse | 15 | description | gene, protein-coding, PROVISIONAL [RefSeq] |
| 1620704 | Vmn1r148 | vomeronasal 1 receptor 148 | ENCODES a protein that exhibits G protein-coupled receptor activity (inferred); pheromone receptor activity (inferred); INVOLVED IN G protein-coupled receptor signaling pathway (inferred); response to pheromone (inferred); sensory perception of chemical stimulus (inferred); FOUND IN membrane (inferr ed); plasma membrane (inferred); INTERACTS WITH epoxiconazole | 7 | 22111656 | 22114094 | Mouse | 15 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 2306481 | Vmn1r160 | vomeronasal 1 receptor 160 | ENCODES a protein that exhibits G protein-coupled receptor activity (inferred); pheromone receptor activity (inferred); INVOLVED IN G protein-coupled receptor signaling pathway (inferred); response to pheromone (inferred); sensory perception of chemical stimulus (inferred); FOUND IN membrane (inferr ed); plasma membrane (inferred); INTERACTS WITH epoxiconazole | 7 | 22570649 | 22571572 | Mouse | 15 | description | gene, protein-coding, PROVISIONAL [RefSeq] |
| 1620705 | Vmn1r172 | vomeronasal 1 receptor 172 | ENCODES a protein that exhibits G protein-coupled receptor activity (inferred); pheromone receptor activity (inferred); INVOLVED IN G protein-coupled receptor signaling pathway (inferred); response to pheromone (inferred); sensory perception of chemical stimulus (inferred); FOUND IN membrane (inferr ed); plasma membrane (inferred); INTERACTS WITH 1,2-dichloroethane; epoxiconazole | 7 | 23357741 | 23360088 | Mouse | 16 | description | gene, protein-coding, VALIDATED [RefSeq] |
| 1614733 | Vmn1r209 | vomeronasal 1 receptor 209 | ENCODES a protein that exhibits G protein-coupled receptor activity (inferred); pheromone receptor activity (inferred); INVOLVED IN G protein-coupled receptor signaling pathway (inferred); response to pheromone (inferred); sensory perception of chemical stimulus (inferred); FOUND IN membrane (inferr ed); plasma membrane (inferred); INTERACTS WITH epoxiconazole | 13 | 22989750 | 22990688 | Mouse | 15 | description | gene, protein-coding, PROVISIONAL [RefSeq] |
| 1553478 | Vmn1r72 | vomeronasal 1 receptor 72 | ENCODES a protein that exhibits G protein-coupled receptor activity (inferred); pheromone receptor activity (inferred); INVOLVED IN G protein-coupled receptor signaling pathway (inferred); response to pheromone (inferred); sensory perception of chemical stimulus (inferred); FOUND IN membrane (inferr ed); plasma membrane (inferred); INTERACTS WITH epoxiconazole; glyphosate; valproic acid | 7 | 11403526 | 11404446 | Mouse | 17 | description | gene, protein-coding, PROVISIONAL [RefSeq] |
| 3753473 | Vmn1r88 | vomeronasal 1 receptor, 88 | ENCODES a protein that exhibits G protein-coupled receptor activity (inferred); pheromone receptor activity (inferred); INVOLVED IN G protein-coupled receptor signaling pathway (inferred); response to pheromone (inferred); sensory perception of chemical stimulus (inferred); FOUND IN membrane (inferr ed); plasma membrane (inferred); INTERACTS WITH epoxiconazole | 7 | 12911646 | 12912596 | Mouse | 15 | description | gene, protein-coding, PROVISIONAL [RefSeq] |
| 1614618 | Zfp953 | zinc finger protein 953 | ENCODES a protein that exhibits metal ion binding (inferred); zinc ion binding (inferred); INVOLVED IN regulation of DNA-templated transcription (inferred); FOUND IN nucleolus (ortholog); INTERACTS WITH (1->4)-beta-D-glucan; 17beta-estradiol; epoxiconazole | 13 | 67487373 | 67508691 | Mouse | 35 | description | gene, protein-coding, PROVISIONAL [RefSeq] |